Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

2018 Long Term Incentive Plan awards

23 Oct 2018 07:00

RNS Number : 8232E
Ideagen PLC
23 October 2018
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

2018 Long Term Incentive Plan awards

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces the award of 1,200,000 share options over the Company's ordinary shares of 1p each ("Ordinary Shares") to Ben Dorks, Chief Executive Officer, under the Company's 2018 Long Term Incentive Plan ("2018 LTIP").

 

On 23 March 2017, the Company made awards to certain directors of share options pursuant to the terms of the 2017 Long Term Incentive Plan ("2017 LTIP").

 

These share options were issued with the principal aim, which has now been achieved, of becoming fully exercisable on the Company achieving a share price of 136 pence, which represented a doubling of the share price from the 68 pence condition set in the previous Long Term Incentive Plan.

 

The principles underpinning the 2018 LTIP are similar to the 2017 LTIP insofar as the awards will be subject to the following challenging performance criteria: one half become eligible to vest on the Company's share price reaching 196 pence over 30 consecutive business days with the remainder becoming eligible to vest on the Company's share price reaching 259 pence over 30 consecutive business days.

 

Options issued pursuant to the 2018 LTIP will not vest until the third anniversary of the grant date. Thereafter, any Ordinary Shares issued in respect of the exercise of any of these options cannot be sold until the fourth anniversary of the grant date except to meet the taxation costs arising on the exercise of those options. They are also subject to continued service throughout as well as the aforementioned achievement of specific performance targets relating to the Company's share price. These options each have an exercise price of 1 penny per Ordinary Share. 

 

Following the award of these options, there are now 9,283,333 options over Ordinary Shares in issue representing 4.2% of the issued share capital of the Company.

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman

Ben Dorks, Chief Executive Officer

Graeme Spenceley, Finance Director

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

Alice Lane (ECM)

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit, Pentana Performance and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 3,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Ben Dorks

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ideagen plc

b)

LEI:

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 penny each

 

GB00B0CM0C50

b)

Nature of the transaction:

Award of share options

c)

Price(s) and volume(s):

 1,200,000 options over ordinary shares of 1 pence each awarded

 

d)

Aggregated information:

· Aggregated volume:

· Price:

 1,200,000 options over ordinary shares of 1 pence each awarded

 

e)

Date of the transaction:

22 October 2018

f)

Place of the transaction:

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMMMZGMZFGRZZ
Date   Source Headline
26th Jan 201610:43 amRNSDirector/PDMR Shareholding
26th Jan 20167:00 amRNSInterim Results
13th Jan 20161:41 pmRNSHolding(s) in Company
22nd Dec 20157:00 amRNSExercise of Options and Total Voting Rights
11th Dec 20159:53 amRNSHolding(s) in Company
25th Nov 20151:42 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSTrading Update
5th Nov 201511:23 amRNSChange of Registered Office Address
29th Oct 20153:59 pmRNSResult of AGM
20th Oct 20157:00 amRNSExercise of Options
7th Oct 20157:00 amRNSNotice of AGM
23rd Sep 20158:15 amRNSEnlighten product wins GRC Innovation Award
3rd Sep 20157:00 amRNSNew Contract Extensions worth £1m
10th Aug 20157:00 amRNSExercise of Options and Total Voting Rights
31st Jul 201511:54 amRNSDirector Dealing
23rd Jul 20157:00 amRNSGrant of Share Options
22nd Jul 20157:00 amRNSFinal Results
9th Jul 20157:00 amRNSNotice of Results
30th Jun 20159:19 amRNSShares Magazine Investor Event
3rd Jun 201511:25 amRNSHolding(s) in Company
21st May 20157:00 amRNSG-Cloud Award and New Contract Win
14th May 20157:00 amRNSPre-Close Trading Update
7th May 20157:00 amRNSExercise of Options and Total Voting Rights
30th Apr 201510:26 amRNSHolding(s) in Company
23rd Apr 201511:55 amRNSHolding(s) in Company
20th Apr 20152:53 pmRNSReplacement Director Dealing & Total Voting Rights
20th Apr 20157:00 amRNSDirector Dealing & Total Voting Rights
15th Apr 201511:25 amRNSHolding(s) in Company
11th Mar 201511:23 amRNSHolding(s) in Company
6th Mar 201512:57 pmRNSHolding(s) in Company
25th Feb 20157:00 amRNSExercise of Options and Total Voting Rights
24th Feb 20157:00 amRNSNew Aviation Contract Wins worth £1m
29th Jan 20157:00 amRNSInterim Results
20th Jan 20153:41 pmRNSHolding(s) in Company
16th Jan 201512:44 pmRNSHolding(s) in Company
16th Jan 201512:42 pmRNSHolding(s) in Company
13th Jan 20151:04 pmRNSCompletion of Acquisition of Gael Limited
9th Jan 201511:55 amRNSHolding(s) in Company
7th Jan 201512:56 pmRNSResult of General Meeting
18th Dec 20147:00 amRNSAcquisition, Placing and Notice of General Meeting
13th Nov 20147:00 amRNSTrading update and Notice of Results
5th Nov 20148:30 amRNSIdeagen selected by NuGen
31st Oct 20141:47 pmRNSResult of AGM
9th Oct 20147:00 amRNSNotice of 2014 Annual General Meeting ("AGM")
2nd Oct 20147:00 amRNSContract Win and Trading Update
4th Aug 20147:00 amRNSIssue of Equity
22nd Jul 20147:00 amRNSFinal Results
10th Jul 20147:00 amRNSNotice of Results
25th Jun 20147:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.